A detailed history of Orion Portfolio Solutions, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Orion Portfolio Solutions, LLC holds 3,541 shares of ALNY stock, worth $861,348. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,541
Previous 3,084 14.82%
Holding current value
$861,348
Previous $749,000 30.04%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$233.81 - $287.01 $106,851 - $131,163
457 Added 14.82%
3,541 $974,000
Q2 2024

Aug 13, 2024

BUY
$143.31 - $247.0 $134,568 - $231,933
939 Added 43.78%
3,084 $749,000
Q1 2024

May 09, 2024

SELL
$146.51 - $198.2 $56,259 - $76,108
-384 Reduced 15.18%
2,145 $320,000
Q4 2023

Feb 09, 2024

SELL
$151.41 - $196.57 $8,478 - $11,007
-56 Reduced 2.17%
2,529 $484,000
Q3 2023

Nov 01, 2023

BUY
$170.77 - $211.65 $39,106 - $48,467
229 Added 9.72%
2,585 $457,000
Q2 2023

Aug 14, 2023

SELL
$185.01 - $212.05 $23,681 - $27,142
-128 Reduced 5.15%
2,356 $447,000
Q1 2023

Aug 30, 2023

BUY
$182.66 - $235.53 $23,380 - $30,147
128 Added 5.43%
2,484 $497,000
Q1 2023

May 15, 2023

BUY
$182.66 - $235.53 $267,414 - $344,815
1,464 Added 143.53%
2,484 $497,000
Q4 2022

Feb 08, 2023

BUY
$185.53 - $241.31 $1,484 - $1,930
8 Added 0.79%
1,020 $242,000
Q3 2022

Nov 09, 2022

BUY
$138.54 - $232.0 $140,202 - $234,784
1,012 New
1,012 $203,000
Q3 2020

Nov 13, 2020

SELL
$121.19 - $165.49 $9,089 - $12,411
-75 Closed
0 $0
Q2 2020

Aug 19, 2020

SELL
$104.21 - $156.44 $7,503 - $11,263
-72 Reduced 48.98%
75 $11,000
Q1 2020

May 15, 2020

BUY
$93.12 - $133.99 $6,704 - $9,647
72 Added 96.0%
147 $16,000
Q4 2019

Feb 14, 2020

BUY
$74.51 - $124.23 $5,588 - $9,317
75 New
75 $9,000

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $29.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Orion Portfolio Solutions, LLC Portfolio

Follow Orion Portfolio Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Portfolio Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orion Portfolio Solutions, LLC with notifications on news.